# Octapharma AB - Inspection Records

Source: https://www.keypedia.com/companies/octapharma-ab/5a456872-4ca6-4418-b006-6e7e219ec262

> Inspection records and compliance data for Octapharma AB in Stockholm, None. Access full analysis and detailed observations.

---

## Details

- Name: Octapharma AB
- FEI Number: 3005559915
- City: Stockholm
- State: None
- Country Name: Sweden
- Address Line 1: Lars Forssells Gata 23
- Zip Code: None

## Related Documents

- [483 - Octapharma AB - 2023-09-19](https://www.keypedia.com/records/483/octapharma-ab/a7d7835f-4227-4c5c-8d98-37f73449dfda) — source: FDA, date: September 19, 2023
- [483 - Octapharma AB - 2023-09-19](https://www.keypedia.com/records/483/octapharma-ab/39c0cc19-3c92-4f74-935f-51aa7ab303f4) — source: FDA, date: September 19, 2023
- [FDA Inspection 1218250 - Octapharma AB - 2023-09-19](https://www.keypedia.com/records/fda_inspections/octapharma-ab/3645f477-d675-40fc-90b8-3704a595408d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 19, 2023
- [FDA Inspection 1070173 - Octapharma AB - 2018-09-28](https://www.keypedia.com/records/fda_inspections/octapharma-ab/d1bd9bce-fbba-4979-be9f-74a49e7eed87) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 28, 2018
- [FDA Inspection 894095 - Octapharma AB - 2014-04-28](https://www.keypedia.com/records/fda_inspections/octapharma-ab/b353da3f-7e1b-492d-8bed-ece62fb5761e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2014
- [FDA Inspection 783783 - Octapharma AB - 2012-01-19](https://www.keypedia.com/records/fda_inspections/octapharma-ab/1a09a3bb-de0f-4a67-b7be-e990f830f4fa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2012
- [FDA Inspection 710676 - Octapharma AB - 2011-01-20](https://www.keypedia.com/records/fda_inspections/octapharma-ab/e46fa3b2-794a-456e-97d5-2b973b8e1194) — classification: Official Action Indicated (OAI), source: FDA, date: January 20, 2011
- [FDA Inspection 580664 - Octapharma AB - 2009-01-29](https://www.keypedia.com/records/fda_inspections/octapharma-ab/aecdcdae-81fa-4620-9ef5-96c6d77149d6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 29, 2009

## Related Companies

- [Resilience US, Inc.](https://www.keypedia.com/companies/resilience-us-inc/864cabb1-d73c-4706-8d04-3e5c2375f44e)
- [BioDuro, LLC](https://www.keypedia.com/companies/bioduro-llc/ea6debd9-54f2-4570-a8b6-f62b6f60c207)
- [Actavis Laboratories UT, Inc.](https://www.keypedia.com/companies/actavis-laboratories-ut-inc/cbe6c043-14c7-4f58-84bf-68647da581f8)
- [Patheon Puerto Rico, Inc.](https://www.keypedia.com/companies/patheon-puerto-rico-inc/e9addf1c-234e-45b2-a136-75152851936b)
- [Almac Pharma Services Limited](https://www.keypedia.com/companies/almac-pharma-services-limited/cbb631be-ab57-4979-8135-9459efb00c73)
- [Qilu Pharmaceutical (Hainan) Co. Ltd.](https://www.keypedia.com/companies/qilu-pharmaceutical-hainan-co-ltd/60dedaab-e32c-493a-894b-9eec7372c066)
- [C.P.M. Contract Pharma GmbH & Co. KG](https://www.keypedia.com/companies/cpm-contract-pharma-gmbh-co-kg/603d56c1-f951-4a2d-9098-cd2fc6ee54f6)
- [AstraZeneca Nijmegen B.V.](https://www.keypedia.com/companies/astrazeneca-nijmegen-bv/29dc14a3-b8e5-4e0a-9399-8d18afc9d686)
- [Unichem Laboratories Limited](https://www.keypedia.com/companies/unichem-laboratories-limited/2b8c7905-52a2-4b2e-a97e-0a1d5b2d88ea)
- [Macleods Pharmaceuticals Limited](https://www.keypedia.com/companies/macleods-pharmaceuticals-limited/cd51cd03-2afe-4dcd-93b4-20beee9d0521)

## Related Officers

- [Olga Simakova](https://www.keypedia.com/people/olga-simakova/2ee5985e-425e-4732-8869-2be861f5d792)
- [Ze Zeuj](https://www.keypedia.com/people/ze-zeuj/b4ca7158-e9ef-49da-aae5-d78b91e36b0f)
- [Robert Scott](https://www.keypedia.com/people/robert-scott/97ee60c1-66a5-475f-9b54-7808c9519d70)
- [Mark L. Baum](https://www.keypedia.com/people/mark-l-baum/03c8bd98-912b-43f9-9e41-6ffb00bc3cfe)